非妇科细胞学标本的细胞-组织学对照实践:美国病理学家学会细胞病理委员会调查
该研究基于美国病理学家学会细胞病理委员会设计的问卷调查,分析非妇科细胞学细胞-组织学对照(CHC)的实践模式。结果显示88.5%的机构开展非妇科CHC,较既往显著增加;执行频率因机构类型而异,诊所或独立实验室及国家/企业实验室显著低于医院和学术医疗中心。大多数CHC在对应手术标本审核时实时同步进行,采样是最常见的不一致原因,两步差异是最常用阈值但定义不一。
要点
- 88.5%的机构开展非妇科细胞学CHC,较既往显著增加。
- 诊所/独立实验室及企业实验室CHC执行频率显著低于医院和学术中心。
- 采样是最常见不一致原因,两步差异为最常用阈值但机构间定义不一。
核心结论
- 非妇科细胞病理的CHC实践与妇科细胞病理CHC实践相似。
研究设计与样本
- 基于美国病理学家学会细胞病理委员会设计并随非妇科细胞病理教育项目邮件发放的问卷调查数据进行分析。
主要发现
- 全球88.5%的机构对非妇科细胞学标本执行CHC,较前些年显著增加。
- CHC执行频率因机构类型而异,诊所或区域/地方独立实验室及国家/企业实验室显著低于医院、大学医院/学术医疗中心和退伍军人事务部/国防部医院机构。
- 大多数CHC在对应手术标本审核时实时同步进行,选择实时同步CHC由判读病理医生、诊断手术活检样本或细胞病理病例的病理医生或两者共同决定。
- 采样是导致细胞学与手术标本不一致的最常见原因。
- 两步差异是最常见的不一致阈值,但该标准在各机构间存在差异,无多数定义。
临床怎么用
- 非妇科细胞学CHC可参考妇科细胞学CHC模式实施,但需注意机构类型差异及不一致阈值定义不统一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Cytologic-histologic correlation (CHC) is a Clinical Laboratory Improvement Amendments-mandated requirement for gynecologic cytology, but no similar requirement exists for nongynecologic cytology. This study presents the findings from a College of American Pathologists survey of nongynecologic cytology practice patterns. OBJECTIVE.—: To survey the current CHC practices for nongynecologic cytology. DESIGN.—: Data were analyzed from a survey developed by the committee and distributed to participants in the Nongynecologic Cytopathology Education Program mailing. RESULTS.—: Adoption of CHC for nongynecologic cytology cases is worldwide, with 88.5% of institutions performing CHC on these specimens, a substantial increase from previous years. Performance of CHC varied by institution type, with clinic or regional/local independent laboratories and national/corporate laboratories performing CHC significantly less frequently than hospitals, university hospitals/academic medical centers, and Veterans Administration/Department of Defense hospital institutions. Most CHC was performed concurrently in real time, when the corresponding surgical specimen was reviewed. Selection for real-time concurrent CHC was by the interpreting pathologist, the pathologist diagnosing the surgical biopsy sample or cytopathology case, or both. Sampling was by far the most common reason for discordance. A 2-step difference was the most frequent threshold for discordance between cytology and surgical specimens, but this criterion varied among institutions, with no majority definition. The positive predictive value of a positive cytology finding was calculated rarely in North American institutions but was calculated more frequently in international institutions. CONCLUSIONS.—: CHC practices for nongynecologic cytopathology mirror those found for CHC of gynecologic cytopathology.
引用
- Nguyen LN, Crothers BA, Souers RJ, et al. Cytologic-Histologic Correlation Practices for Nongynecologic Cytology Specimens: A Survey by the College of American Pathologists Cytopathology Committee. Arch Pathol Lab Med. 2024. PMID: 38051268. doi:10.5858/arpa.2023-0140-CP
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。